| Literature DB >> 35059495 |
Farah Naaz Kazi1, J V Sharma1, Shaurav Ghosh1, D Prashanth1, V Om Pramod Kumar Raja1.
Abstract
Background Necrotizing fasciitis (NF) is a life-threatening condition requiring urgent attention. It is clinically difficult to diagnose, linked to severe systemic toxicity, and has poor prognosis. In 2001, Andreasen and coworkers described the "Finger test" for the diagnosis of NF. Subsequent studies have suggested early recognition and management of NF. In this study, we compare the LRINEC-Laboratory Risk Indicator for Necrotizing Fasciitis-scoring system with the "Finger test" and histopathological examination for diagnosis of NF. Results In our study, LRINEC scoring system and Finger test are statistically significant in the diagnosis of NF. Males are more frequently affected, and the most common organism causing NF is Staphylococcus . Histopathology remained the gold standard for diagnosis of NF, while LRINEC score and Finger test were good diagnostic tools for early diagnosis, with sensitivities of 83.33 and 86.11%, respectively. Conclusion LRINEC laboratory-based scoring system is easy and reliable diagnostic tool though histopathology remains the gold standard. There is statistically significant correlation between histopathology and laboratory criteria. LRINEC test is independently better than bedside Finger test alone or combined LRINEC and bedside Finger test. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ).Entities:
Keywords: Finger test; LRINEC; histopathology; necrotizing fasciitis
Year: 2022 PMID: 35059495 PMCID: PMC8763456 DOI: 10.1055/s-0041-1740629
Source DB: PubMed Journal: Surg J (N Y) ISSN: 2378-5128
Comparison of clinical variables according to LRINEC results
| Variables | LRINEC result | Total | ||
|---|---|---|---|---|
| Negative | Positive | |||
| Age | 60.22 ± 13.89 | 56.12 ± 13.66 | 57.05 ± 13.64 | 0.435 |
| HB (g/dL) | 11.15 ± 2.61 | 10.33 ± 2.07 | 10.52 ± 2.19 | 0.333 |
| TLC (/cu.mm) | 14,900.00 ± 6,523.80 | 20,577.41 ± 67,985.90 | 19,300.00 ± 7,065.19 | 0.032* |
| Serum creatinine (micmol/L) | 86.66 ± 20.00 | 207.41 ± 146.85 | 180.25 ± 138.85 | 0.020* |
| Serum sodium (mmol/L) | 138.11 ± 4.85 | 134.09 ± 5.50 | 135.00 ± 5.57 | 0.056+ |
| Serum glucose (mmol/L) | 9.33 ± 3.66 | 14.76 ± 9.72 | 13.54 ± 8.98 | 0.111 |
| C-reactive protein (mg/L) | 97.55 ± 20.70 | 181.29 ± 31.91 | 162.45 ± 46.10 | <0.001** |
Abbreviations: HB, hemoglobin; LRINEC, laboratory risk indicator for necrotizing fasciitis; TLC, total leukocyte count.
Significant values.
Finger test and histopathology distribution in relation to LRINEC results in patients studied
| Bedside Finger test | LRINEC result | Total | |
|---|---|---|---|
| Negative | Positive | ||
| Negative | 3 (33.3%) | 3 (9.7%) | 6 (15%) |
| Positive | 6 (66.7%) | 28 (90.3%) | 34 (85%) |
| Total | 9 (100%) | 31 (100%) | 40 (100%) |
|
| LRINEC result | Total | |
| Negative | Positive | ||
| Necrotized tissues | 6 (66.7%) | 30 (96.8%) | 36 (90%) |
| Inflamed tissue | 3 (33.3%) | 1 (3.2%) | 4 (10%) |
| Total | 9 (100%) | 31 (100%) | 40 (100%) |
Abbreviation: LRINEC, laboratory risk indicator for necrotizing fasciitis.
Pus C/S distribution in relation to LRINEC and histopathology results in patients studied
| Pus C/S | LRINEC result | Total | Histopathology | Total | ||||
|---|---|---|---|---|---|---|---|---|
| Negative | Positive | Inflamed tissue | Necrotized tissues | |||||
|
| 0 (0%) | 2 (6.5%) | 2 (5%) | 1.000 | 0 (0%) | 2 (5.6%) | 2 (5%) | 1.000 |
|
| 0 (0%) | 1 (3.2%) | 1 (2.5%) | 1.000 | 0 (0%) | 1 (2.8%) | 1 (2.5%) | 1.000 |
|
| 1 (11.1%) | 5 (16.1%) | 6 (15%) | 1.000 | 0 (0%) | 6 (16.7%) | 6 (15%) | 1.000 |
|
| 1 (11.1%) | 0 (0%) | 1 (2.5%) | 0.225 | 1 (25%) | 0 (0%) | 1 (2.5%) | 0.100 |
|
| 1 (11.1%) | 2 (6.5%) | 3 (7.5%) | 0.545 | 0 (0%) | 3 (8.3%) | 3 (7.5%) | 1.000 |
|
| 0 (0%) | 3 (9.7%) | 3 (7.5%) | 1.000 | 1 (25%) | 2 (5.6%) | 3 (7.5%) | 0.277 |
|
| 1 (11.1%) | 14 (45.2%) | 15 (37.5%) | 0.117 | 0 (0%) | 15 (41.7%) | 15 (37.5%) | 0.278 |
|
| 5 (55.6%) | 4 (12.9%) | 9 (22.5%) | 0.016* | 2 (50%) | 7 (19.4%) | 9 (22.5%) | 0.213 |
Abbreviations: C/S, culture and sensitivity; LRINEC, laboratory risk indicator for necrotizing fasciitis.
Frequency distribution of age and gender distribution in relation to LRINEC and histopathology results in patients studied
| Variables | LRINEC result | Total | Histopathology | Total | ||||
|---|---|---|---|---|---|---|---|---|
| Negative | Positive | Inflamed tissue | Necrotized tissues | |||||
| Age | ||||||||
| ≤40 | 0 (0%) | 4 (12.9%) | 4 (10%) | 0.247 | 0 (0%) | 4 (11.1%) | 4 (10%) | 0.658 |
| 41–50 | 3 (33.3%) | 6 (19.4%) | 9 (22.5%) | 2 (50%) | 7 (19.4%) | 9 (22.5%) | ||
| 51–60 | 2 (22.2%) | 7 (22.6%) | 9 (22.5%) | 0 (0%) | 9 (25%) | 9 (22.5%) | ||
| 61–70 | 2 (22.2%) | 13 (41.9%) | 15 (37.5%) | 2 (50%) | 13 (36.1%) | 15 (37.5%) | ||
| > 70 | 2 (22.2%) | 1 (3.2%) | 3 (7.5%) | 0 (0%) | 3 (8.3%) | 3 (7.5%) | ||
| Gender | ||||||||
| Female | 2 (22.2%) | 6 (19.4%) | 8 (20%) | 1.000 | 0 (0%) | 8 (22.2%) | 8 (20%) | 0.566 |
| Male | 7 (77.8%) | 25 (80.6%) | 32 (80%) | 4 (100%) | 28 (77.8%) | 32 (80%) | ||
| Total | 9 (100%) | 31 (100%) | 40 (100%) | 4 (100%) | 36 (100%) | 40 (100%) | ||
Abbreviation: LRINEC, laboratory risk indicator for necrotizing fasciitis.
Association of Finger test and LRINEC results in association with histopathology findings
| Bedside Finger test | Histopathology | Total | |
|---|---|---|---|
| Inflamed tissue | Necrotized tissues | ||
| Negative | 1 (25%) | 5 (13.9%) | 6 (15%) |
| Positive | 3 (75%) | 31 (86.1%) | 34 (85%) |
| Total | 4 (100%) | 36 (100%) | 40 (100%) |
|
| Histopathology | Total | |
|
|
| ||
| Negative | 3 (75%) | 6 (16.7%) | 9 (22.5%) |
| Positive | 1 (25%) | 30 (83.3%) | 31 (77.5%) |
| Total | 4 (100%) | 36 (100%) | 40 (100%) |
Abbreviation: LRINEC, laboratory risk indicator for necrotizing fasciitis.
Association of LRINEC results with the histopathology findings and LRINEC results
| Histopathology | Finger test | Total | ||
|---|---|---|---|---|
| Negative | Positive | |||
|
| ||||
| LRINEC result | ||||
| ➢ Negative | 0 (0%) | 3 (100%) | 3 (75%) | 0.250 |
| ➢ Positive | 1 (100%) | 0 (0%) | 1 (25%) | |
| ➢ Total | 1 (100%) | 3 (100%) | 4 (100%) | |
|
| ||||
| LRINEC result | ||||
| ➢ Negative | 3 (60%) | 3 (9.7%) | 6 (16.7%) | 0.024* |
| ➢ Positive | 2 (40%) | 28 (90.3%) | 30 (83.3%) | |
| ➢ Total | 5 (100%) | 31 (100%) | 36 (100%) | |
|
| ||||
| LRINEC result | ||||
| ➢ Negative | 3 (50%) | 6 (17.6%) | 9 (22.5%) | 0.115 |
| ➢ Positive | 3 (50%) | 28 (82.4%) | 31 (77.5%) | |
| ➢ Total | 6 (100%) | 34 (100%) | 40 (100%) | |
Abbreviation: LRINEC, laboratory risk indicator for necrotizing fasciitis.
Association of LRINEC + bedside Finger test results with histopathology findings
| LRINEC result + Finger test | Histopathology | Total | |
|---|---|---|---|
| Inflamed tissue | Necrotized tissues | ||
| Negative | 0 | 3 (8.3%) | 3 (7.5%) |
| Positive | 4 (100.0%) | 33 (91.7%) | 37 (92.5%) |
Abbreviation: LRINEC, laboratory risk indicator for necrotizing fasciitis.
p = 1.000; Significant, Fisher's Exact Test